Stock Events

Stock Events

Scancell Hldgs 

GBX11.25
20
-GBX0.25-2.17% Thursday 15:27

Statistics

Day High
11.5
Day Low
11
52W High
14
52W Low
7.8
Volume
538,249.36
Avg. Volume
-
Mkt Cap
116.75M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29JanExpected
Q4 2022
Q3 2023
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
-1.4
-1.03
-0.66
-0.3
Expected EPS
N/A
Actual EPS
-0.609645221573542

Financials

-260.5%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
942.2MRevenue
-2.45BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SCLP.LSE. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap10.61B
Moderna is a leader in mRNA technology, similar to Scancell's focus on novel immunotherapies, making them direct competitors in the vaccine and therapeutic space.
BioNTech
BNTX
Mkt Cap24.99B
BioNTech competes in the development of novel immunotherapies for cancer and infectious diseases, directly aligning with Scancell's research focus.
Novavax
NVAX
Mkt Cap1.36B
Novavax is involved in the development of vaccines for infectious diseases, competing with Scancell's infectious disease vaccine programs.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is a biopharmaceutical company that develops drugs for infectious diseases, directly competing with Scancell's therapeutic development.
AMGEN
AMGN
Mkt Cap160.66B
Amgen focuses on human therapeutics, including treatments for cancer and inflammation, overlapping with Scancell's therapeutic areas.
Pfizer
PFE
Mkt Cap140.15B
Pfizer develops vaccines and therapeutics for various diseases, competing with Scancell in the broader pharmaceutical and biotech industry.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its pharmaceutical division Janssen, competes in the development of vaccines and therapeutics, similar to Scancell's focus areas.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is involved in the development of vaccines and cancer treatments, making it a competitor in Scancell's key research areas.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals focuses on developing monoclonal antibodies, a technology that competes with Scancell's immunotherapy approaches.
Merck
MRK
Mkt Cap214.76B
Merck & Co. develops vaccines and cancer immunotherapies, directly competing with Scancell's product development pipeline.

About

Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel vaccines and antibody medicines to treat unmet needs in cancer and infectious diseases. The company's product candidates include SCIB1, an ImmunoBody cancer vaccine for the treatment of metastatic melanoma; SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumours, including non-small cell lung cancer; and Modi-1 that is in phase I/II clinical trials for the treatment of head and neck, triple negative breast, ovarian, and renal cancers. It also develops Modi-2, which targets homocitrullinated cancer antigens. In addition, the company develops SCOV1 and SCOV2 COVIDITY, a DNA vaccine against the SARS-CoV-2 virus. Scancell Holdings plc was founded in 1997 and is based in Oxford, the United Kingdom.
Show more...
CEO
Dr. Phillip John L'Huillier MBA, Ph.D.
Employees
60
Country
GB
ISIN
GB00B63D3314

Listings

LSE
GB
SCLP.LSE
OTC Link
US
SCNLF
F
DE
SCP.F

0 Comments

Share your thoughts

FAQ

What is Scancell Hldgs stock price today?▼
The current price of SCLP.LSE is GBX11.25 GBX — it has decreased by -2.17% in the past 24 hours. Watch Scancell Hldgs stock price performance more closely on the chart.
What is Scancell Hldgs stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Scancell Hldgs stocks are traded under the ticker SCLP.LSE.
Is Scancell Hldgs stock price growing?▼
SCLP.LSE stock has fallen by -3.43% compared to the previous week, the month change is a -9.64% fall, over the last year Scancell Hldgs has showed a +42.41% increase.
What is Scancell Hldgs market cap?▼
Today Scancell Hldgs has the market capitalization of 116.75M
When is the next Scancell Hldgs earnings date?▼
Scancell Hldgs is going to release the next earnings report on October 23, 2026.
What were Scancell Hldgs earnings last quarter?▼
SCLP.LSE earnings for the last quarter are -0.61 GBX per share, whereas the estimation was N/A GBX resulting in a N/A surprise. The estimated earnings for the next quarter are N/A GBX per share.
What is Scancell Hldgs revenue for the last year?▼
Scancell Hldgs revenue for the last year amounts to 942.2M GBX.
What is Scancell Hldgs net income for the last year?▼
SCLP.LSE net income for the last year is -2.45B GBX.
How many employees does Scancell Hldgs have?▼
As of April 04, 2026, the company has 60 employees.
In which sector is Scancell Hldgs located?▼
Scancell Hldgs operates in the Health Care sector.
When did Scancell Hldgs complete a stock split?▼
The last stock split for Scancell Hldgs was on July 26, 2011 with a ratio of 10:1.
Where is Scancell Hldgs headquartered?▼
Scancell Hldgs is headquartered in Oxford, GB.